Citadel Advisors
BVS icon

Citadel Advisors’s Bioventus BVS Stock Holding History

Citadel Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Buy
68,800
+2,300
+3% +$22K ﹤0.01% 9257
2026
Q1 		$607K Buy
66,500
+17,400
+35% +$146K ﹤0.01% 8821
2025
Q4 		$365K Buy
49,100
+24,400
+99% +$175K ﹤0.01% 9729
2025
Q3 		$165K Sell
24,700
-13,200
-35% -$91.6K ﹤0.01% 11455
2025
Q2 		$251K Buy
37,900
+20,300
+115% +$144K ﹤0.01% 10202
2025
Q1 		$161K Buy
17,600
+3,400
+24% +$34K ﹤0.01% 10761
2024
Q4 		$149K Sell
14,200
-1,100
-7% -$13K ﹤0.01% 10894
2024
Q3 		$183K Buy
15,300
+8,500
+125% +$73.5K ﹤0.01% 10288
2024
Q2 		$39.1K Buy
6,800
+400
+6% +$2.19K ﹤0.01% 12016
2024
Q1 		$33.3K Sell
6,400
-4,900
-43% -$23.9K ﹤0.01% 12594
2023
Q4 		$59.6K Buy
11,300
+4,800
+74% +$19K ﹤0.01% 11599
2023
Q3 		$21.4K Sell
6,500
-800
-11% -$2.81K ﹤0.01% 12575
2023
Q2 		$21.1K Buy
+7,300
New +$14K ﹤0.01% 12685
2023
Q1 		– Sell
-4,600
Closed -$12K – 14750
2022
Q4 		$12K Buy
+4,600
New +$20.1K ﹤0.01% 13534

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's BVS Position: Q2 2026 in Review

Citadel Advisors sold out of Bioventus (BVS) in Q2 2026, closing a stake of 17,085 shares — an estimated $163K sold.

Citadel Advisors first reported a position in BVS in Q2 2021 and held it in 18 quarters. The position peaked at $3.21M in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Citadel Advisors reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 17,085 Bioventus shares in Q2 2026, an estimated $163K.
  • Citadel Advisors first reported a position in Bioventus in Q2 2021 and held it in 18 quarters.
  • Citadel Advisors's Bioventus position peaked at $3.21M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.